Case Report: The First Reported Concurrence of Wilson Disease and Bilateral Retinitis Pigmentosa

Overview

Journal Front Med (Lausanne)

Specialty General Medicine

Date 2022 May 16

PMID 35573004

Authors

Zifan Ye

Xiuhua Jia

Xin Liu

Qi Zhang

Kaijun Wang

Min Chen

Affiliations

Soon will be listed here.

Abstract

Background: Wilson disease (WD) and retinitis pigmentosa (RP) are common genetic disorders in clinical practice, however, the concurrence of WD and RP has never been reported before. WD occurs due to mutations that cause copper metabolic abnormalities; in turn, change in copper metabolism has been suggested to be related with RP. Here, we report the first case of concurrent WD and bilateral RP, and investigate possible pathogenesis to illuminate whether the two genetic disorders are causality or coincidence.

Case Presentation: The patient was a 43-year-old Chinese female diagnosed with WD 12 years ago. She had suffered from night blindness since childhood and faced diminution of bilateral vision within 10 years, for which she was referred to our Eye Center during hospitalization for routine copper excretion treatment. The ceruloplasmin, skull magnetic resonance imaging (MRI), and abdominal ultrasound results accorded with hepatolenticular degeneration. Ocular examinations revealed corneal Kayser-Fleischer (K-F) ring, sunflower-like cataract, retinal osteocyte-like pigmentation, bilateral atrophy of outer retina, cystoid macular edema (CME), and tubular vision in both eyes. Phacoemulsification combined with intraocular lens implantation was performed in the right and left eye, but there was limited improvement in her visual acuity. Whole exome sequencing (WES) detected a deleterious homozygous mutation in the gene related to WD, and a homozygous mutation in the gene very likely to cause RP.

Conclusions: We reported the first case of concurrent WD and RP. WES detected two pathogenic gene mutations, and . Though we cannot completely rule out a causal effect of WD-related abnormal copper metabolism with RP, we speculate that the two gene mutations lead to the coincidence of the two genetic disorders, respectively.

References

Cozma I, Atherley C, James N . Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asian and white patients. Eye (Lond). 2004; 19(8):924-5. DOI: 10.1038/sj.eye.6701677. View

Rao S, Satapathy M, Sitaramayya A . Copper metabolism in retinitis pigmentosa patients. Br J Ophthalmol. 1981; 65(2):127-30. PMC: 1039440. DOI: 10.1136/bjo.65.2.127. View

Bai Z, Xie Y, Liu L, Shao J, Liu Y, Kong X . Genetic investigation of 211 Chinese families expands the mutational and phenotypical spectra of hereditary retinopathy genes through targeted sequencing technology. BMC Med Genomics. 2021; 14(1):92. PMC: 8008643. DOI: 10.1186/s12920-021-00935-w. View

Svetel M, Bozic M, Vitkovic J, Jovanovic C, Dragasevic N, Pekmezovic T . Optical coherence tomography in patients with Wilson's disease. Acta Neurol Scand. 2021; 144(2):149-154. DOI: 10.1111/ane.13431. View

Triolo G, Pierro L, Battaglia Parodi M, De Benedetto U, Gagliardi M, Manitto M . Spectral domain optical coherence tomography findings in patients with retinitis pigmentosa. Ophthalmic Res. 2013; 50(3):160-4. DOI: 10.1159/000351681. View

Kircheva N, Dobrev S, Nikolova V, Angelova S, Dudev T . Zinc and Its Critical Role in : Insights from DFT/SMD Calculations. Inorg Chem. 2020; 59(23):17347-17355. DOI: 10.1021/acs.inorgchem.0c02664. View

Saito T . Presenting symptoms and natural history of Wilson disease. Eur J Pediatr. 1987; 146(3):261-5. DOI: 10.1007/BF00716470. View

Ehlers N, Bulow N . Clinical copper metabolism parameters in patients with retinitis pigmentosa and other tapeto-retinal degenerations. Br J Ophthalmol. 1977; 61(9):595-6. PMC: 1043054. DOI: 10.1136/bjo.61.9.595. View

Ugarte M, Osborne N, Brown L, Bishop P . Iron, zinc, and copper in retinal physiology and disease. Surv Ophthalmol. 2013; 58(6):585-609. DOI: 10.1016/j.survophthal.2012.12.002. View

10.

Zigrai M, Vyskocil M, Tothova A, Veres P, Bluska P, Valkovic P . Late-Onset Wilson's Disease. Front Med (Lausanne). 2020; 7:26. PMC: 7016193. DOI: 10.3389/fmed.2020.00026. View

11.

Xie J, Wu Z . Wilson's Disease in China. Neurosci Bull. 2017; 33(3):323-330. PMC: 5567514. DOI: 10.1007/s12264-017-0107-4. View

12.

Gahlot D, KHOSLA P, MAKASHIR P, Vasuki K, Basu N . Copper metabolism in retinitis pigmentosa. Br J Ophthalmol. 1976; 60(11):770-4. PMC: 1042836. DOI: 10.1136/bjo.60.11.770. View

13.

Langwinska-Wosko E, Litwin T, Szulborski K, Czlonkowska A . Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's disease. Metab Brain Dis. 2015; 31(2):405-15. PMC: 4791478. DOI: 10.1007/s11011-015-9776-8. View

14.

Yang M, So K, Lam W, Lo A . Cell Ferroptosis: New Mechanism and New Hope for Retinitis Pigmentosa. Cells. 2021; 10(8). PMC: 8393369. DOI: 10.3390/cells10082153. View

15.

Karcioglu Z, Stout R, Hahn H . Serum zinc levels in retinitis pigmentosa. Curr Eye Res. 1984; 3(8):1043-8. DOI: 10.3109/02713688409011750. View

16.

Zhong H, Molday L, Molday R, Yau K . The heteromeric cyclic nucleotide-gated channel adopts a 3A:1B stoichiometry. Nature. 2002; 420(6912):193-8. PMC: 2877395. DOI: 10.1038/nature01201. View

17.

Cater M, La Fontaine S, Shield K, Deal Y, Mercer J . ATP7B mediates vesicular sequestration of copper: insight into biliary copper excretion. Gastroenterology. 2006; 130(2):493-506. DOI: 10.1053/j.gastro.2005.10.054. View

18.

Kajiwara K, Berson E, Dryja T . Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science. 1994; 264(5165):1604-8. DOI: 10.1126/science.8202715. View

19.

Lorincz M . Neurologic Wilson's disease. Ann N Y Acad Sci. 2010; 1184:173-87. DOI: 10.1111/j.1749-6632.2009.05109.x. View

20.

Gao Q, Liu Y, Lei X, Deng Q, Tong Y, Du L . A Novel CNGA1 Gene Mutation (c.G622A) of Autosomal Recessive Retinitis Pigmentosa Leads to the CNGA1 Protein Reduction on Membrane. Biochem Genet. 2019; 57(4):540-554. DOI: 10.1007/s10528-019-09907-3. View